BioNTech and DualityBio’s ADC hits in late-stage breast cancer trial in Chinanews2025-09-05T11:04:34+00:00September 5th, 2025|Endpoints News|
Merck KGaA finds its next R&D leader; Exelixis retools management team as medical chief leavesnews2025-09-05T11:00:32+00:00September 5th, 2025|Endpoints News|
Hengrui does another US deal, this time in Cytokinetics’ cardio arenanews2025-09-05T08:01:47+00:00September 5th, 2025|Endpoints News|
FDA publishes drug rejection letters for ongoing applications for the first timenews2025-09-04T19:20:52+00:00September 4th, 2025|Endpoints News|
RFK Jr. battles growing GOP frustration over vaccine policiesnews2025-09-04T19:03:50+00:00September 4th, 2025|Endpoints News|
J&J, Bristol Myers lose appeals cases challenging Medicare price negotiationnews2025-09-04T18:29:54+00:00September 4th, 2025|Endpoints News|
AstraZeneca ends manufacturing license at Indian plant as it exits the site news2025-09-04T16:16:12+00:00September 4th, 2025|Endpoints News|
We’re doing a Health Tech meet-up in NYC — see you there?news2025-09-04T15:13:10+00:00September 4th, 2025|Endpoints News|
MindMed details Phase 2b LSD data in medical journalnews2025-09-04T15:00:19+00:00September 4th, 2025|Endpoints News|
Exothera shutters; Lotte Biologics’ latest contract with an unnamed US clientnews2025-09-04T14:19:31+00:00September 4th, 2025|Endpoints News|
